BMGL NASDAQ
Basel Medical Group Ltd Ordinary Shares
1W: -11.3%
1M: -33.6%
3M: -53.4%
YTD: -52.1%
1Y: -84.2%
$3.28
+0.26 (+8.61%)
Weekly Expected Move ±35.4%
$1
$2
$3
$4
$6
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Income Trends
Revenue
$11M
+12.6% ▲
3Y CAGR: +2.0%
Gross Profit
$9M
+12.7% ▲
3Y CAGR: +1.2%
Operating Income
-$2M
-199.4% ▼
Net Income
-$12M
-683.2% ▼
EPS (Diluted)
$0.00
-100.0% ▼
EBITDA
-$11M
-457.6% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|
| Revenue | $11M | $10M | $10M | $11M |
| YoY Growth | +0.0% | -9.0% | +3.6% | +12.6% |
| Cost of Revenue | $2M | $2M | $2M | $3M |
| Gross Profit | $8M | $7M | $8M | $9M |
| Gross Margin | 79.6% | 75.9% | 77.6% | 77.7% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $4M | $3M | $4M | $7M |
| Operating Expenses | $6M | $5M | $6M | $11M |
| Operating Income | $2M | $2M | $2M | -$2M |
| Operating Margin | 23.2% | 20.6% | 21.8% | -19.3% |
| Interest Expense | $321K | $239K | $176K | $204K |
| Income Before Tax | $2M | $2M | $2M | -$13M |
| Tax Expense | $408K | $348K | $332K | -$417K |
| Net Income | $2M | $2M | $2M | -$12M |
| Net Margin | 18.6% | 18.4% | 20.6% | -106.8% |
| EPS (Diluted) | $0.11 | $0.10 | $0.11 | $0.00 |
| EBITDA | $3M | $3M | $3M | -$11M |
| Shares Outstanding | 19M | 19M | 19M | 0 |